Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-005735

Chief Business Officer acquired 20,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Savill Corrine · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-17 Grant or award : show line 1 in the form +20,500 170,115 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-17 Grant or award : show line 2 in the form Stock Option (Right to Buy) +41,000 41,000 D
Loading xslF345X03/doc4.xml…